265JPY
10.53 BJPY
67.49 BJPY
23.93 M
About KISSEI PHARMACEUTICAL CO
Sector
CEO
Mutsuo Kanzawa
Headquarters
Matsumoto
Website
Employees (FY)
1.8 K
Founded
1946
ISIN
JP3240600001
FIGI
BBG000BJSD42
Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. It operates through the following segments: Pharmaceuticals, Information Service, and Others. The Pharmaceuticals segment researches, develops, manufactures, and markets drugs, which are used in the fields of urology, dialysis, women's health, ophthalmology, endocrinology and metabolism. The Information Service segment offers information services to use in IT and capital investment. The Others segment includes merchandise sales and construction contractors. The company was founded on August 9, 1946 and is headquartered in Matsumoto, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4547 is 3420 JPY — it has decreased by 1.58% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange KISSEI PHARMACEUTICAL CO stocks are traded under the ticker 4547.
KISSEI PHARMACEUTICAL CO is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
4547 stock is 2.66% volatile and has beta coefficient of 0.40. Check out the list of the most volatile stocks — is KISSEI PHARMACEUTICAL CO there?
One year price forecast for KISSEI PHARMACEUTICAL CO has a max estimate of 4600 JPY and a min estimate of 3400 JPY.
4547 earnings for the last quarter are 52.71 JPY per share, whereas the estimation was 51.41 JPY resulting in a 2.53% surprise. The estimated earnings for the next quarter are 53.67 JPY per share. See more details about KISSEI PHARMACEUTICAL CO earnings.
KISSEI PHARMACEUTICAL CO revenue for the last quarter amounts to 17.67 B JPY despite the estimated figure of 18.30 B JPY. In the next quarter revenue is expected to reach 19.50 B JPY.
Yes, you can track KISSEI PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
4547 stock has fallen by 4.74% compared to the previous week, the month change is a 4.87% fall, over the last year KISSEI PHARMACEUTICAL CO has showed a 28.19% increase.
4547 net income for the last quarter is 2.66 B JPY, while the quarter before that showed 2.41 B JPY of net income which accounts for 10.15% change. Track more KISSEI PHARMACEUTICAL CO financial stats to get the full picture.
Today KISSEI PHARMACEUTICAL CO has the market capitalization of 154.47 B, it has increased by 2.83% over the last week.
KISSEI PHARMACEUTICAL CO dividend yield was 3.03% in 2022, and payout ratio reached 35.04%. The year before the numbers were 2.19% and 19.99% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4547 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KISSEI PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 1.80 K employees. See our rating of the largest employees — is KISSEI PHARMACEUTICAL CO on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KISSEI PHARMACEUTICAL CO technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KISSEI PHARMACEUTICAL CO stock shows the buy signal. See more of KISSEI PHARMACEUTICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on KISSEI PHARMACEUTICAL CO future price: according to them, 4547 price has a max estimate of 4600.00 JPY and a min estimate of 3400.00 JPY. Read a more detailed KISSEI PHARMACEUTICAL CO forecast: see what analysts think of KISSEI PHARMACEUTICAL CO and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KISSEI PHARMACEUTICAL CO EBITDA is 6.74 B JPY, and current EBITDA margin is 4.39%. See more stats in KISSEI PHARMACEUTICAL CO financial statements.